CHELSEA HENRIQUES: Open Payments
NPI 1114508140 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 47 payments from 19 companies in 2025. Trend: 2023 $239 · 2024 $175 · 2025 $1,213
Food & beverage: $1,213
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $184 |
| Lilly USA, LLC | 2 | $158 |
| SOBI, INC | 5 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $114 |
| AstraZeneca Pharmaceuticals LP | 4 | $97 |
| Merck Sharp & Dohme LLC | 3 | $87 |
| PFIZER INC. | 4 | $82 |
| Stemline Therapeutics Inc. | 2 | $60 |
| Janssen Biotech, Inc. | 2 | $43 |
| ARRAY BIOPHARMA INC | 2 | $41 |
Products named: KISQALI, KEYTRUDA, INLURIYO, Nubeqa, XTANDI, VERZENIO, Doptelet, IMFINZI.
Industry payments across AZ — which companies pay providers there.
